Amendment No. 3 to Employment Agreement October 13, 2017Employment Agreement • November 14th, 2017 • Orexigen Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledNovember 14th, 2017 Company Industry JurisdictionReference is made to the Employment Agreement (the “Agreement”) dated February 3, 2015 by and between Orexigen Therapeutics, Inc. (“Orexigen” or the “Company”) with its principal place of business located at 3344 N. Torrey Pines Ct., Suite 200, La Jolla, CA 92037 and Jason Keyes (“Executive”), and Amendment No. 2 to the Employment Agreement dated June 16, 2016 (the “Second Amendment”). All capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Agreement.
Amendment No. 3 to Employment Agreement October 13, 2017Employment Agreement • November 14th, 2017 • Orexigen Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledNovember 14th, 2017 Company Industry JurisdictionReference is made to the Employment Agreement (the “Agreement”) dated February 23, 2015 by and between Orexigen Therapeutics, Inc. (“Orexigen” or the “Company”) with its principal place of business located at 3344 N. Torrey Pines Ct., Suite 200, La Jolla, CA 92037 and Peter Flynn (“Executive”), and Amendment No. 2 to the Employment Agreement dated June 16, 2016 (the “Second Amendment”). All capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Agreement.
Amendment No. 2 to Employment Agreement JuNE 16, 2016Employment Agreement • November 14th, 2017 • Orexigen Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledNovember 14th, 2017 Company Industry JurisdictionReference is made to the Employment Agreement (the “Agreement”) dated February 23, 2015 by and between Orexigen Therapeutics, Inc. (“Orexigen” or the “Company”) with its principal place of business located at 3344 N. Torrey Pines Ct., Suite 200, La Jolla, CA 92037 and Peter Flynn (“Executive”), and Amendment No. 1 to the Employment Agreement dated February 2, 2016 (the “First Amendment”). All capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Agreement.